Google is using AI to unlock nature’s hidden machinery and open new frontiers in medicine, from decoding the intricate workings of enzymes in the human body to mapping the complexity of our brains. The technology is helping scientists unravel mysteries that have long stood in the way of medical breakthroughs.
For generations, medical researchers have painstakingly pieced together the mechanisms of disease, often spending years or even entire careers on research that produces more questions than answers. AI is beginning to change that, allowing scientists to sift through enormous volumes of biological information, identify previously invisible patterns and pursue discoveries at speeds once considered impossible.
Google is applying AI across the scientific process, from understanding disease at the molecular level to designing potential treatments and helping physicians identify illnesses before they become life-threatening.
At the heart of this research is AlphaFold, the groundbreaking AI system developed by Google DeepMind under the leadership of Demis Hassabis. The British computer scientist, who shared the 2024 Nobel Prize in chemistry for his contributions to protein structure prediction, helped solve one of biology’s most stubborn puzzles: predicting how proteins fold into the intricate three-dimensional structures that determine their functions.
In diagnosis and treatment, time is critical. Researchers across the technology and medical fields are applying AI to vast troves of scans and mammograms to assess the likelihood of patients developing diseases later in life. Perhaps the biggest application of AI is its ability to digest massive volumes of data in just hours, find hidden commonalities or even rule out suspected contributors to disease. Such capabilities hold immense potential, not just for analyzing scans but also for finding needles in haystacks when it comes to developing drugs to fight disease.
For example, researchers at the Institute for Global Health in Barcelona used AlphaFold to virtually screen 30,000 compounds against Chagas disease, a potentially deadly parasitic illness affecting roughly 8 million people. The work identified two existing FDA-approved drugs as possible candidates for repurposing, potentially shortening the process of developing a treatment by years.
Google’s AlphaGenome Atlas is helping researchers understand how tiny changes in DNA influence biological processes. Scientists at the University of Exeter used the technology to analyze genetic information from more than 54,000 people, identifying variations associated with important proteins involved in aging and cellular oxygen sensing.
And then there is the brain, arguably nature’s most elaborate piece of engineering. Google worked with Harvard researchers to reconstruct a microscopic fragment of human brain tissue at nanoscale resolution, exposing a labyrinth of neurons and connections. Although the fragment represents only a minuscule portion of the brain, the map offers scientists an unprecedented opportunity to investigate the circuitry underlying human thought and neurological disease.
AI is also helping researchers create biological machinery. Google’s AlphaProtein Novo system has demonstrated the ability to design entirely new enzymes, including proteins capable of producing chemical building blocks used in medicines and breaking down certain chemicals found in plastics.
In collaboration with Stanford University, Google contributed AI technology to research that achieved a genetic diagnosis through whole-genome sequencing in less than eight hours. And mammography research involving 125,000 women found that an AI system detected 25% of interval cancers missed by conventional screening, while suggesting the potential to substantially reduce radiologists’ workloads.
These advances remain at different stages of development, and promising laboratory results do not automatically translate into approved treatments or better patient outcomes. Clinical validation, physician oversight and access to the technology remain essential.
The scale of the effort is remarkable. Google says its researchers have published 90 peer-reviewed papers addressing disease over the past five years, generating more than 90,000 citations. So far in 2026, Google.org has provided more than $60 million to organizations applying advanced AI models to disease research and treatment.
